ArticleCancer medicine2023

Procalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T-cell therapy recipients.

Marissa Z Powell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.